As of May 2024 Kymera Therapeutics has a market cap of $2.15 Billion. This makes Kymera Therapeutics the world's 4033th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.15 B | 52.41% |
2023 | $1.41 B | 3.16% |
2022 | $1.36 B | -58.03% |
2021 | $3.26 B | 18.36% |
2020 | $2.75 B |
On May 14th, 2024 the market cap of Kymera Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.61 B | -71.54% | ๐บ๐ธ USA |